| TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells S Mariathasan, SJ Turley, D Nickles, A Castiglioni, K Yuen, Y Wang, ... Nature 554 (7693), 544-548, 2018 | 3717 | 2018 |
| A consensus molecular classification of muscle-invasive bladder cancer A Kamoun, A de Reyniès, Y Allory, G Sjödahl, AG Robertson, R Seiler, ... European urology 77 (4), 420-433, 2020 | 927 | 2020 |
| Molecular classification of urothelial carcinoma: global mRNA classification versus tumour‐cell phenotype classification G Sjödahl, P Eriksson, F Liedberg, M Höglund The Journal of pathology 242 (1), 113-125, 2017 | 307 | 2017 |
| Toward a molecular pathologic classification of urothelial carcinoma G Sjödahl, K Lövgren, M Lauss, O Patschan, S Gudjonsson, G Chebil, ... The American journal of pathology 183 (3), 681-691, 2013 | 199 | 2013 |
| Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling P Roswall, M Bocci, M Bartoschek, H Li, G Kristiansen, S Jansson, S Lehn, ... Nature medicine 24 (4), 463-473, 2018 | 157 | 2018 |
| A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort N Marzouka, P Eriksson, C Rovira, F Liedberg, G Sjödahl, M Höglund Scientific reports 8 (1), 3737, 2018 | 156 | 2018 |
| A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma O Patschan, G Sjödahl, G Chebil, K Lövgren, M Lauss, S Gudjonsson, ... European urology 68 (5), 824-832, 2015 | 140 | 2015 |
| Biological determinants of bladder cancer gene expression subtypes M Aine, P Eriksson, F Liedberg, G Sjödahl, M Höglund Scientific reports 5 (1), 10957, 2015 | 133 | 2015 |
| Cell-type-specific gene programs of the normal human nephron define kidney cancer subtypes D Lindgren, P Eriksson, K Krawczyk, H Nilsson, J Hansson, S Veerla, ... Cell reports 20 (6), 1476-1489, 2017 | 89 | 2017 |
| Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems P Eriksson, M Aine, S Veerla, F Liedberg, G Sjödahl, M Höglund BMC medical genomics 8, 1-15, 2015 | 83 | 2015 |
| Different responses to neoadjuvant chemotherapy in urothelial carcinoma molecular subtypes G Sjödahl, J Abrahamsson, K Holmsten, C Bernardo, G Chebil, ... European urology 81 (5), 523-532, 2022 | 81 | 2022 |
| On Molecular Classification of Bladder Cancer: Out of One, Many. M Aine, P Eriksson, F Liedberg, M Höglund, G Sjödahl European urology 68 (6), 921-923, 2015 | 67 | 2015 |
| Discordant molecular subtype classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases G Sjödahl, P Eriksson, K Lövgren, C Bernardo, I Nordentoft, L Dyrskjøt, ... Modern Pathology 31 (12), 1869-1881, 2018 | 52 | 2018 |
| Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma G Sjödahl, P Eriksson, O Patschan, NAD Marzouka, L Jakobsson, ... International Journal of Cancer 146 (9), 2636-2647, 2020 | 51 | 2020 |
| Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma M Aine, G Sjödahl, P Eriksson, S Veerla, D Lindgren, M Ringnér, ... Genome medicine 7, 1-20, 2015 | 43 | 2015 |
| HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts P Eriksson, G Sjödahl, G Chebil, F Liedberg, M Höglund Oncotarget 8 (30), 48905, 2017 | 42 | 2017 |
| FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation M Foth, NFB Ismail, JSC Kung, D Tomlinson, MA Knowles, P Eriksson, ... The Journal of pathology 246 (3), 331-343, 2018 | 35 | 2018 |
| Molecular pathology of the luminal class of urothelial tumors C Bernardo, P Eriksson, N Marzouka, F Liedberg, G Sjödahl, M Höglund The Journal of Pathology 249 (3), 308-318, 2019 | 34 | 2019 |
| Molecular subtype classification of urothelial carcinoma in Lynch syndrome C Therkildsen, P Eriksson, M Höglund, M Jönsson, G Sjödahl, M Nilbert, ... Molecular Oncology 12 (8), 1286-1295, 2018 | 34 | 2018 |
| Molecular subtypes applied to a population-based modern cystectomy series do not predict cancer-specific survival P Kollberg, G Chebil, P Eriksson, G Sjödahl, F Liedberg Urologic Oncology: Seminars and Original Investigations 37 (10), 791-799, 2019 | 31 | 2019 |
